What are Collegium Pharmaceutical, Inc.'s profit margins?

Collegium Pharmaceutical, Inc. (COLL) runs a 60.7% gross margin and a 23.7% operating margin, with a 9.4% net margin.

Where do Collegium Pharmaceutical, Inc.'s ratios come from?

Every ratio is computed from Collegium Pharmaceutical, Inc.'s SEC filings — trailing-twelve-month flows over period-end balances. Valuation multiples combine those fundamentals with market data, recomputed each period. Switch between quarterly, annual, and TTM, or open any ratio for its full history and peer comparisons.

Collegium Pharmaceutical, Inc. COLL Ratios & Valuation

Income Statement Balance Sheet Cash Flow Ratios Segments

Quarterly Annual TTM

YoY QoQ

Simplified Detailed

	Q1 '26	Q4 '25	Q3 '25	Q2 '25	Q1 '25
Profitability
Gross margin	60.7%+1.3pp	59.3%+2.1pp	57.2%+0.5pp	56.7%-1.0pp	57.7%-2.1pp
Operating margin	23.7%+0.7pp	23%+2.3pp	20.7%+2.4pp	18.4%-3.0pp	21.4%-5.5pp
Net margin	9.4%+1.4pp	8.1%+0.3pp	7.7%+2.6pp	5.1%-1.5pp	6.6%-4.3pp
EBITDA margin	31.1%+0.5pp	30.7%-5.3pp	36%-4.5pp	40.4%-9.6pp	50%-3.7pp
Free cash flow margin	41.4%-0.5pp	42%+3.8pp	38.2%+8.4pp	29.9%-1.1pp	31%-2.7pp
Returns
Return on equity	27.4%+3.7pp	23.7%+0.7pp	23%+6.8pp	16.2%-3.1pp	19.2%-13.4pp
Return on assets	4.6%+0.8pp	3.8%+0.2pp	3.6%+0.9pp	2.7%-0.5pp	3.2%-1.7pp
Return on invested capital	172.1%+46.5pp	125.6%+57.5pp	68.1%-35.5pp	103.6%-50.6pp	154.3%—
Efficiency
Asset turnover	0.5×0.0×	0.5×0.0×	0.5×-0.1×	0.5×+0.1×	0.5×0.0×
Inventory turnover	13.3×+0.5×	12.8×+4.3×	8.5×-0.8×	9.3×+1.1×	8.2×+0.7×
Liquidity
Current ratio	1.7×+0.1×	1.6×+0.2×	1.4×+0.2×	1.2×+0.1×	1.1×+0.1×
Quick ratio	1.7×+0.2×	1.5×+0.3×	1.3×+0.2×	1.1×+0.1×	1×+0.1×
Cash ratio	0.7×+0.1×	0.6×+0.2×	0.3×+0.1×	0.3×0.0×	0.2×+0.1×
Leverage
Debt-to-equity	0×0.0×	0×0.0×	0×0.0×	0×0.0×	0×0.0×
Debt-to-assets	0×0.0×	0×0.0×	0×0.0×	0×0.0×	0×0.0×
Net debt / EBITDA	-1.1×-0.1×	-1×-0.5×	-0.5×-0.1×	-0.4×-0.1×	-0.3×-0.1×
Interest coverage	2.4×+0.3×	2.2×+0.3×	1.8×+0.3×	1.6×-0.3×	1.8×-0.5×
Per Share
Book value per share	$7.80+3.6%	$7.53+8.0%	$6.97+17.3%	$5.94-16.8%	$7.14+25.1%
Valuation
Market capitalization	$1.15B+17.9%	$1.46B+32.8%	$1.1B+13.9%	$967.8M+0.9%	$959.13M+3.8%
Enterprise value	$869.67M-0.3%	$1.22B+27.0%	$958.04M+11.8%	$856.64M+1.0%	$848.54M+1.7%
Price / earnings	15.4×-6.9×	23.3×+4.4×	18.9×-7.8×	26.7×+4.8×	21.9×+8.5×
Price / sales	1.5×0.0×	1.9×+0.4×	1.5×+0.1×	1.4×-0.1×	1.4×0.0×
Price / book	3.6×-0.5×	4.9×+0.8×	4×-0.2×	4.2×+0.1×	4.1×+0.1×
EV / EBITDA	3.4×+0.9×	5.1×+1.6×	3.5×+0.5×	3×+0.4×	2.6×+0.1×
EV / sales	1.1×-0.2×	1.6×+0.3×	1.3×+0.1×	1.2×-0.1×	1.3×0.0×
Free cash flow yield	29.2%+7.7pp	22.4%-3.9pp	26.2%+4.4pp	21.8%+0.3pp	21.5%-1.5pp
Earnings yield	6.6%+2.1pp	4.3%-1.0pp	5.3%+1.6pp	3.7%-0.8pp	4.6%-2.9pp
PEG ratio	0.2×—	——	——	——	——

Chart any of these lines over time, or line them up against competitors.

Compare these in charts →

Ask your AI about Collegium Pharmaceutical, Inc..

Connect your AI assistant and get a quick read on the numbers, right in your chat.

Connect your AI

Claude

Questions, answered.

What are Collegium Pharmaceutical, Inc.'s profit margins?: Collegium Pharmaceutical, Inc. (COLL) runs a 60.7% gross margin and a 23.7% operating margin, with a 9.4% net margin.
Where do Collegium Pharmaceutical, Inc.'s ratios come from?: Every ratio is computed from Collegium Pharmaceutical, Inc.'s SEC filings — trailing-twelve-month flows over period-end balances. Valuation multiples combine those fundamentals with market data, recomputed each period. Switch between quarterly, annual, and TTM, or open any ratio for its full history and peer comparisons.